LMB’s newly recruited Group Leader weighs in on various aspects of Alzheimer’s Disease, from the clinical implications of deciphering Tau filaments in brains of people suffering from neurodegenerative diseases, to designing precise drugs. More…
Home > LMB In The News > Benjamin Falcon discusses his research in Neuronet’s first newsletter